Clearmind Medicine Inc.CMNDNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +1098.89% | +195.79% | +54.79% | +50.07% | +35.46% |
| Weighted Average Shares Diluted Growth | +1098.89% | +195.79% | +54.79% | +50.07% | +35.46% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +4.77% | +49.59% | +5.04% | +9.44% | +79.42% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +69.65% | -28.50% | -40.79% | -51.80% | -15.58% |
| Book Value per Share Growth | -63.31% | -79.02% | -67.64% | -79.71% | -71.47% |
| Debt Growth | +0.00% | -46.47% | +0.00% | -53.65% | +3270.38% |
| R&D Expense Growth | +30.58% | +123.80% | +41.81% | +108.35% | -13.12% |
| SG&A Expenses Growth | -17.10% | -2.28% | -11.61% | -39.81% | -5.31% |